Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
FDC On Other Exchanges
Symbol
Exchange
FDC is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

fdc ltd (FDC) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for FDC LTD (FDC)

Related News

No related news articles were found.

fdc ltd (FDC) Related Businessweek News

No Related Businessweek News Found

fdc ltd (FDC) Details

FDC Limited manufactures and markets various healthcare products in India and internationally. The company primarily offers therapeutics, foods, and bulk drugs. Its therapeutic products include anti fungals/dermatological, anti-anaemic, anti-diabetic, anti-haemorrhagics, anti-spasmodics, antibiotics/antibacterials, antiemetic/antinauseant, antiulcerants, antivirals, calcium supplements, cardio-vascular, central nervous system, ENT and related products, genito urinary system and sex hormones, laxatives, musculo-skeletal system, ophthalmics, orthopaedics, otologicals, pre-probiotic, respiratory and antiallergic, and stomatologicals. The company’s food products comprise anti-oxidants; balanced energy drinks; and vitamins and nutraceuticals. Its bulk drug products consist of albuterol sulfate, betaxolol hydrochloride, brimonidine tartrate, bromhexine hydrochloride, cinnarizine, dorzolamide hydrochloride, econazole nitrate, fluconazole, flunarizine dihydrochloride, flurbiprofen, flurbiprofen sodium, ketoconazole, levoalbuterol HCL, levoalbuterol sulfate/tartrate, meclizine HCL, miconazole base, miconazole nitrate, oxbutynin hydrochloride, R-flurbiprofen, salbutamol sulphate, and timolol maleate. The company also have bulk drugs under development that consist of Azelastine HCL, Brinzolamide, Duloxetine HCl, Gemifloxacine Mesylate, Latanoprost, Levo-Betaxolol HCl, Olopatadine HCl, Pregabalin, Rupatadine Fumarate, and Voriconazole. FDC Limited was founded in 1936 and is headquartered in Mumbai, India.

Founded in 1936

fdc ltd (FDC) Top Compensated Officers

Joint Managing Director and Executive Directo...
Total Annual Compensation: 4.1M
Chairman, Managing Director, Member of Shareh...
Total Annual Compensation: 4.1M
Whole Time Director and Member of Shareholder...
Total Annual Compensation: 3.4M
Whole Time Director
Total Annual Compensation: 3.2M
Compensation as of Fiscal Year 2014.

fdc ltd (FDC) Key Developments

FDC Limited, Board Meeting, Feb 07, 2015

FDC Limited, Board Meeting, Feb 07, 2015. Agenda: To consider the quarterly results.

FDC Limited to Report Q3, 2015 Results on Feb 07, 2015

FDC Limited announced that they will report Q3, 2015 results on Feb 07, 2015

FDC Limited Reports Unaudited Standalone Earnings Results for the Second Quarter and Half Year Ended September 30, 2014

FDC Limited reported unaudited standalone earnings results for the second quarter and half year ended September 30, 2014. For the quarter, the company reported net sales (net of excise duty) of INR 2,394.273 million compared to INR 2,264.054 million a year ago. Profit from operations before other income and finance costs was INR 580.253 million compared to INR 565.965 million a year ago. Profit from ordinary activities before tax was INR 668.166 million against INR 653.522 million a year ago. Net profit was INR 477.968 million or INR 2.69 per basic and diluted share compared to INR 490.709 million or INR 2.76 per basic and diluted share a year ago. For the half year, the company reported net sales (net of excise duty) of INR 4,565.965 million compared to INR 4,337.587 million a year ago. Profit from operations before other income and finance costs was INR 906.813 million compared to INR 1,023.653 million a year ago. Profit from ordinary activities before tax was INR 1,142.067 million against INR 1,211.326 million a year ago. Net profit was INR 820.973 million or INR 4.62 per basic and diluted share compared to INR 921.513 million or INR 5.16 per basic and diluted share a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FDCLT:IN 154.75 INR -1.30

FDC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for FDC.
View Industry Companies
 

Industry Analysis

FDC

Industry Average

Valuation FDC Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FDC LTD, please visit www.fdcindia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.